Compugen (CGEN) Tax Provisions (2013 - 2026)
Compugen's (CGEN) quarterly Tax Provisions came in at $5000.0 in Q1 2026, down 83.87% year-on-year from $31000.0 in Q1 2025, and down 95.37% quarter-over-quarter from $108000.0 in Q4 2025.
Compugen (CGEN) Tax Provisions (2013 - 2026) Analysis & Trends
Compugen has disclosed Tax Provisions across 9 years of filings, most recently posting $5000.0 for Q1 2026.
- Tax Provisions for Q1 2026 came in at $5000.0, down 83.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $28000.0 (up 100.62% YoY), and the FY2025 annual result was $54000.0, down 98.81% from the prior year.
- Tax Provisions came in at $5000.0 for Q1 2026 at Compugen, down from $108000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $9.0 million in Q4 2023 to a low of -$4.5 million in Q3 2024.
- The 5-year median for Tax Provisions is $5000.0 (2026), against an average of $357307.7.
- Across the five-year window, Tax Provisions jumped 15427.59% in 2023 and slumped 173.91% in 2024, its largest moves.
- Compugen's Tax Provisions stood at $58000.0 in 2022, then surged by 15427.59% to $9.0 million in 2023, then tumbled by 99.96% to $4000.0 in 2024, then soared by 2600.0% to $108000.0 in 2025, then sank by 95.37% to $5000.0 in 2026.
- The last three Tax Provisions figures came in at $5000.0 (Q1 2026), $108000.0 (Q4 2025), and -$40000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 108,000.00 |
| Sep 30, 2025 | -40,000.00 |
| Jun 30, 2025 | -45,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | -4.50 Mn |
| Jun 30, 2024 | -17,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 9.01 Mn |
| Jun 30, 2023 | 23,000.00 |
| Mar 31, 2023 | 13,000.00 |
| Dec 31, 2022 | 58,000.00 |
| Sep 30, 2021 | 2.02 Mn |
| Dec 31, 2015 | 390,000.00 |
| Dec 31, 2014 | 300,000.00 |
| Jun 30, 2014 | -60,000.00 |
| Dec 31, 2013 | 345,000.00 |
| Sep 30, 2013 | 155,000.00 |